Thomas Hassell, PhD
Vice President / IAVI
International AIDS Vaccine Initiative 125 Broad Street, 9th Floor New York, NY 10004
Thomas Hassell leads IAVI’s efforts to rapidly advance the most promising vaccine and biologics candidates from the laboratory into clinical trials, accelerating the product development process.
Hassell has more than 30 years of industry experience with several leading vaccine developers and has led efforts to take early stage vaccine candidates for several major diseases from ideas, all the way through to licensure.
Training and Education
Postdoctoral Fellow, Vaccines, Massachusetts Institute of Technology
PhD, Mammalian Cell Culture, Manchester Metropolitan University
BSc, Microbiology, Manchester Metropolitan University